Treatment satisfaction in patients with type 2 diabetes is significantly improved with liraglutide, the once-daily GLP-1 analogue versus sitagliptin, both combined with metformin

被引：0
|
作者：
Montanya Mias, E. [1 ]
Cuddihy, R. [2 ]
Pratley, R. [3 ]
Hammer, M. [4 ]
Thomsen, A. [4 ]
Davies, M. J. [5 ]
机构：
[1] IDIBELL Hosp Univ Bellvitge, Barcelona, Spain
[2] Int Diabet Ctr, Minneapolis, MN USA
[3] Univ Vermont, Burlington, VT 05405 USA
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ Leicester, Leicester LE1 7RH, Leics, England
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
832
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Liraglutide, a once-daily human GLP-1 analogue, in type 2 diabetes provides similar glycaemic control with reduced body weight compared with glimepiride when added to metformin
    Hermansen, K.
    Nauck, M. A.
    Frid, A.
    Shah, N. S.
    Tankova, T.
    Mitha, I. H.
    During, M.
    Zdravkovic, M.
    Matthews, D.
    DIABETOLOGIA, 2008, 51 : S358 - S358
  • [22] Safety, tolerability, pharmacokineties and pharmacodynamics of the once-daily GLP-1 analogue liraglutide in healthy Japanese subjects
    Irie, Shin
    Matsumura, Yoriko
    Zdravkovic, Milan
    Jacobsen, Lisbeth V.
    Kageyama, Shigeru
    DIABETES, 2007, 56 : A540 - A540
  • [23] The effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide
    Kapitza, Christoph
    Flint, Anne
    Spitzer, Heike
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [24] Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide
    Kapitza, Christoph
    Zdravkovic, Milan
    Zijlstra, Eric
    Segel, Stine
    Heise, Tim
    Flint, Anne
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 951 - 955
  • [25] Absence of QTc Prolongation in a Thorough QT Study With Subcutaneous Liraglutide, a Once-Daily Human GLP-1 Analog for Treatment of Type 2 Diabetes
    Chatterjee, Dhruba J.
    Khutoryansky, Naum
    Zdravkovic, Milan
    Sprenger, Craig R.
    Litwin, Jeffrey S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (11): : 1353 - 1362
  • [26] Significantly better glycemic control and weight reduction with liraglutide, a once-daily human GLP-1 analog, compared with insulin glargine:: All as add-on to metformin and a sulfonylurea in type 2 diabetes
    Russell-Jones, David
    Vaag, Allan
    Schmitz, Ole
    Sethi, Bipin K.
    Lalic, Nebojsa
    Antic, Slobodan S.
    Zdravkovic, Milan
    Ravn, Gabriela M.
    Simo, Rafael
    DIABETES, 2008, 57 : A159 - A160
  • [27] In subjects with type 2 diabetes, liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure with negligible impact from weight loss
    Fonseca, V. A.
    Henry, R. R.
    Tabanera y Palacios, R.
    Brett, J.
    Plutzky, J.
    DIABETOLOGIA, 2010, 53
  • [28] Erratum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
    A Astrup
    R Carraro
    N Finer
    A Harper
    M Kunesova
    M E J Lean
    L Niskanen
    M F Rasmussen
    A Rissanen
    S Rössner
    M J Savolainen
    L Van Gaal
    International Journal of Obesity, 2012, 36 : 890 - 890
  • [29] Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes
    Matthews, D. R.
    Marre, M.
    Le-Thi, T. D.
    Zdravkovic, M.
    Simo, R.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S356 - S356
  • [30] Switching from Sitagliptin to Liraglutide, in Combination with Metformin, Improves Treatment Satisfaction in Patients with Type 2 Diabetes
    Montanya, Eduard
    Pratley, Richard
    Nauck, Michael
    Bailey, Timothy
    Garber, Alan
    Filetti, Sebastiano
    Thomsen, Anne B.
    Hammer, Mette
    Davies, Melanie
    DIABETES, 2011, 60 : A307 - A307
12345